(5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione

C75H76N18O16S2 — CID 158615326

IUPAC(5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione
SMILESCOc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCN(C)CC4)nc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCN(C)CC4)s3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCOCC4)s3)NC(=O)NC1=O)C2
InChIInChI=1S/C26H27N7O5.C25H26N6O5S.C24H23N5O6S/c1-31-9-11-32(12-10-31)22(30-37)21-6-3-17(14-27-21)7-8-26(24(35)28-25(36)29-26)16-33-15-18-4-5-19(38-2)13-20(18)23(33)34;1-29-9-11-30(12-10-29)21(28-35)20-6-5-18(37-20)7-8-25(23(33)26-24(34)27-25)15-31-14-16-3-4-17(36-2)13-19(16)22(31)32;1-34-16-3-2-15-13-29(21(30)18(15)12-16)14-24(22(31)25-23(32)26-24)7-6-17-4-5-19(36-17)20(27-33)28-8-10-35-11-9-28/h3-6,13-14,37H,9-12,15-16H2,1-2H3,(H2,28,29,35,36);3-6,13,35H,9-12,14-15H2,1-2H3,(H2,26,27,33,34);2-5,12,33H,8-11,13-14H2,1H3,(H2,25,26,31,32)/t26-;25-;24-/m111/s1
InChIKeyHXHYRCLINVVASU-BEEYYNDZSA-N
MW1549.68 g/mol
LogP1.60
Rot. Bonds12

About (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione

(5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione (PubChem CID 158615326) has the molecular formula C75H76N18O16S2 and a molecular weight of 1549.68 g/mol. Its IUPAC name is (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione.

Molecular Properties

Compound Name(5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione
PubChem CID158615326
Molecular FormulaC75H76N18O16S2
Molecular Weight1549.68 g/mol
Exact Mass1548.51
IUPAC Name(5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione
SMILESCOc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCN(C)CC4)nc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCN(C)CC4)s3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCOCC4)s3)NC(=O)NC1=O)C2
InChIInChI=1S/C26H27N7O5.C25H26N6O5S.C24H23N5O6S/c1-31-9-11-32(12-10-31)22(30-37)21-6-3-17(14-27-21)7-8-26(24(35)28-25(36)29-26)16-33-15-18-4-5-19(38-2)13-20(18)23(33)34;1-29-9-11-30(12-10-29)21(28-35)20-6-5-18(37-20)7-8-25(23(33)26-24(34)27-25)15-31-14-16-3-4-17(36-2)13-19(16)22(31)32;1-34-16-3-2-15-13-29(21(30)18(15)12-16)14-24(22(31)25-23(32)26-24)7-6-17-4-5-19(36-17)20(27-33)28-8-10-35-11-9-28/h3-6,13-14,37H,9-12,15-16H2,1-2H3,(H2,28,29,35,36);3-6,13,35H,9-12,14-15H2,1-2H3,(H2,26,27,33,34);2-5,12,33H,8-11,13-14H2,1H3,(H2,25,26,31,32)/t26-;25-;24-/m111/s1
InChIKeyHXHYRCLINVVASU-BEEYYNDZSA-N
XLogP1.60
TPSA399.31 Ų
H-Bond Donors9
H-Bond Acceptors24
Rotatable Bonds12
Heavy Atoms111
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001549.68
LogP ≤ 51.60
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione?
The IUPAC name of (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione (CID 158615326) is (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione.
What is the SMILES notation for (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione?
The canonical SMILES for (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione is COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCN(C)CC4)nc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCN(C)CC4)s3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(C#Cc3ccc(C(=NO)N4CCOCC4)s3)NC(=O)NC1=O)C2.
What is the InChIKey of (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione?
The InChIKey is HXHYRCLINVVASU-BEEYYNDZSA-N. The full InChI is InChI=1S/C26H27N7O5.C25H26N6O5S.C24H23N5O6S/c1-31-9-11-32(12-10-31)22(30-37)21-6-3-17(14-27-21)7-8-26(24(35)28-25(36)29-26)16-33-15-18-4-5-19(38-2)13-20(18)23(33)34;1-29-9-11-30(12-10-29)21(28-35)20-6-5-18(37-20)7-8-25(23(33)26-24(34)27-25)15-31-14-16-3-4-17(36-2)13-19(16)22(31)32;1-34-16-3-2-15-13-29(21(30)18(15)12-16)14-24(22(31)25-23(32)26-24)7-6-17-4-5-19(36-17)20(27-33)28-8-10-35-11-9-28/h3-6,13-14,37H,9-12,15-16H2,1-2H3,(H2,28,29,35,36);3-6,13,35H,9-12,14-15H2,1-2H3,(H2,26,27,33,34);2-5,12,33H,8-11,13-14H2,1H3,(H2,25,26,31,32)/t26-;25-;24-/m111/s1.
What are the key properties of (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione?
(5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione has a molecular weight of 1549.68 g/mol, XLogP of 1.60, 12 rotatable bonds, 9 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-5-[2-[6-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]-3-pyridinyl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-[N-hydroxy-C-(4-methylpiperazin-1-yl)carbonimidoyl]thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[2-[5-(N-hydroxy-C-morpholin-4-ylcarbonimidoyl)thiophen-2-yl]ethynyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione is sourced from PubChem (CID 158615326), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).